NOTCH3 expression did not significantly correlate with the prognosis of patients with lung cancer (PPS HR = 1.19, 95% CI = 0.92–1.54, P = 0.18) or breast cancer (OS HR = 0.85, 95% CI = 0.61–2.03, P = 0.098; PPS HR = 1.2, 95% CI = 0.95–1.51, P = 0.13) (Fig. 3L,N,Q). This evidence concerns the gene NOTCH3 and lung carcinoma.